Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MAP3K5 |
| Upstream (Parents) |
|---|
| (<<) BMPR2 → MAP3K5 |
| (<<) DDX18 → MAP3K5 |
| (<<) DUSP6 → MAP3K5 |
| (<<) DYNC1LI2 → MAP3K5 |
| (<<) ELF1 → MAP3K5 |
| (<<) EML4 → MAP3K5 |
| (<<) KCTD12 → MAP3K5 |
| (<<) NCOA3 → MAP3K5 |
| (<<) NRIP1 → MAP3K5 |
| (<<) RAC3 → MAP3K5 |
| (<<) SFXN4 → MAP3K5 |
| (<<) SLC20A1 → MAP3K5 |
| (<<) UBE2E3 → MAP3K5 |
| (<<) YWHAB → MAP3K5 |
| Downstream (Children) |
|---|
| MAP3K5 → BRCA1 (>>) |
| MAP3K5 → CDK6 (>>) |
| MAP3K5 → COIL (>>) |
| MAP3K5 → ETS1 (>>) |
| MAP3K5 → HSPA4 (>>) |
| MAP3K5 → IMPA1 (>>) |
| MAP3K5 → MAP6D1 (>>) |
| MAP3K5 → MYO1E (>>) |
| MAP3K5 → NFKBIZ (>>) |
| MAP3K5 → PLA2G4A (>>) |
| MAP3K5 → PRKX (>>) |
| MAP3K5 → PTPLA (>>) |
| MAP3K5 → TMEM87B (>>) |
